EXOPULSE Mollii Suit, Spasticity, Muscular Oxygenation & Multiple Sclerosis (ENNOX 2)

Clinical trial NCT05912595 · UNKNOWN

Trial details

NCT number: NCT05912595
Sponsor: Sheikh Shakhbout Medical City
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Sclerosis, Multiple MS (Multiple Sclerosis)Spastic Spasticity, Muscle Oxygen Consumption

Start date: 2023-05-18
Primary completion: 2024-03-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.